California Public Employees Retirement System’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-64,028
Closed -$2.84M 2614
2021
Q1
$2.84M Sell
64,028
-12,799
-17% -$703K ﹤0.01% 1791
2020
Q4
$4.21M Sell
76,827
-1,400
-2% -$51K ﹤0.01% 1524
2020
Q3
$1.79M Buy
78,227
+2,893
+4% +$71.3K ﹤0.01% 1882
2020
Q2
$1.58M Buy
75,334
+7,592
+11% +$137K ﹤0.01% 1934
2020
Q1
$945K Buy
67,742
+18,842
+39% +$373K ﹤0.01% 2049
2019
Q4
$1.11M Buy
48,900
+34,514
+240% +$576K ﹤0.01% 2309
2019
Q3
$168K Buy
+14,386
New +$179K ﹤0.01% 2979
2019
Q1
Sell
-26,752
Closed -$396K 3230
2018
Q4
$396K Hold
26,752
﹤0.01% 2650
2018
Q3
$659K Buy
+26,752
New +$580K ﹤0.01% 2548

Other funds holding RCKT

California Public Employees Retirement System's RCKT Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Rocket Pharmaceuticals (RCKT) in Q2 2021, closing a stake of 64,028 shares — an estimated $2.84M sold.

California Public Employees Retirement System first reported a position in RCKT in Q3 2018 and held it in 9 quarters. The position peaked at $4.21M in Q4 2020. 150 funds tracked by Wall St. Rank hold RCKT as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Rocket Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 64,028 Rocket Pharmaceuticals shares in Q2 2021, an estimated $2.84M.
  • California Public Employees Retirement System first reported a position in Rocket Pharmaceuticals in Q3 2018 and held it in 9 quarters.
  • California Public Employees Retirement System's Rocket Pharmaceuticals position peaked at $4.21M in Q4 2020.
  • 150 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.